JNJ - CIK 0000200406
The table below shows JOHNSON & JOHNSON's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $2.51B | $4.17B | $3.66B | $3.26B | $3.98B | $4.07B |
| Capital expenditure | $1.05B | $795.00M | $807.00M | $863.00M | $607.00M | $677.00M |
| Investing cash flow | -$1.04B | -$297.00M | -$464.00M | $3.31B | -$3.63B | -$185.00M |
| Dividends paid | - | - | - | - | - |
JOHNSON & JOHNSON reported operating cash flow of $24.53B for fiscal year 2025. That is up 1.1% from $24.27B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $18.77B (FY 2017) to $24.53B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $4.03B | $2.13B | $1.48B | $3.54B | $1.58B | $1.44B |
| Financing cash flow | $530.00M | $10.42B | $546.00M | $6.14B | -$4.38B | -$5.13B |